scholarly article | Q13442814 |
P50 | author | Erik De Clercq | Q13578863 |
Christophe Pannecouque | Q50551511 | ||
Dirk Daelemans | Q50777234 | ||
P2093 | author name string | Brigitte Rosenwirth | |
Jean-Maurice Dumont | |||
P2860 | cites work | HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. | Q34985945 |
P433 | issue | 2 | |
P304 | page(s) | 418-421 | |
P577 | publication date | 2009-10-24 | |
P1433 | published in | Antiviral Research | Q4775352 |
P1476 | title | Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycle | |
P478 | volume | 85 |
Q28537731 | Chemical derivatives of a small molecule deubiquitinase inhibitor have antiviral activity against several RNA viruses |
Q36993953 | Correlation of naturally occurring HIV-1 resistance to DEB025 with capsid amino acid polymorphisms |
Q26828727 | Curing a viral infection by targeting the host: the example of cyclophilin inhibitors |
Q38061056 | Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms |
Q24614498 | HIV type 1 Gag as a target for antiviral therapy |
Q55280981 | Host-targeting therapies for hepatitis C virus infection: current developments and future applications. |
Q30317509 | Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir |
Q38035344 | Recent advances targeting innate immunity-mediated therapies against HIV-1 infection. |
Search more.